These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15947039)

  • 1. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro.
    Shimizu I; Iida T; Horiuchi N; Caterina MJ
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1378-85. PubMed ID: 15947039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and pharmacological characterization of mouse TRPV1.
    Correll CC; Phelps PT; Anthes JC; Umland S; Greenfeder S
    Neurosci Lett; 2004 Nov; 370(1):55-60. PubMed ID: 15489017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence for functional TRPV1 vanilloid receptors in rat hippocampal nerve terminals.
    Köfalvi A; Oliveira CR; Cunha RA
    Neurosci Lett; 2006 Jul; 403(1-2):151-6. PubMed ID: 16672175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.
    Seabrook GR; Sutton KG; Jarolimek W; Hollingworth GJ; Teague S; Webb J; Clark N; Boyce S; Kerby J; Ali Z; Chou M; Middleton R; Kaczorowski G; Jones AB
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1052-60. PubMed ID: 12438527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high concentration of resiniferatoxin inhibits ion channel function in clonal neuroendocrine cells.
    Sugimoto K; Kissin I; Strichartz G
    Anesth Analg; 2008 Jul; 107(1):318-24. PubMed ID: 18635503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid.
    El Kouhen R; Surowy CS; Bianchi BR; Neelands TR; McDonald HA; Niforatos W; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2005 Jul; 314(1):400-9. PubMed ID: 15837819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin.
    Kanai Y; Hara T; Imai A
    J Pharm Pharmacol; 2006 Apr; 58(4):489-93. PubMed ID: 16597366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.
    Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M
    Circ Res; 2007 Apr; 100(7):1063-70. PubMed ID: 17347480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.
    Sanchez MG; Sanchez AM; Collado B; Malagarie-Cazenave S; Olea N; Carmena MJ; Prieto JC; Diaz-Laviada I I
    Eur J Pharmacol; 2005 May; 515(1-3):20-7. PubMed ID: 15913603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat.
    Varga A; Németh J; Szabó A; McDougall JJ; Zhang C; Elekes K; Pintér E; Szolcsányi J; Helyes Z
    Neurosci Lett; 2005 Sep; 385(2):137-42. PubMed ID: 15950380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat.
    Jakab B; Helyes Z; Varga A; Bölcskei K; Szabó A; Sándor K; Elekes K; Börzsei R; Keszthelyi D; Pintér E; Petho G; Németh J; Szolcsányi J
    Eur J Pharmacol; 2005 Jul; 517(1-2):35-44. PubMed ID: 15978575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxin.
    Rigoni M; Trevisani M; Gazzieri D; Nadaletto R; Tognetto M; Creminon C; Davis JB; Campi B; Amadesi S; Geppetti P; Harrison S
    Br J Pharmacol; 2003 Mar; 138(5):977-85. PubMed ID: 12642400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
    Sándor K; Helyes Z; Elekes K; Szolcsányi J
    Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical acetone treatment induces neurogenic oedema on the sensitized mouse ear: an in vivo study using transient receptor potential vanilloid 1 (TRPV1) receptor knockout mice.
    Pozsgai G; Sándor K; Perkecz A; Szolcsányi J; Helyes Z; Brain SD; Pintér E
    Inflamm Res; 2007 Nov; 56(11):459-67. PubMed ID: 18224287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
    Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of transient receptor potential vanilloid-1 on neural responses to acids by the chorda tympani, glossopharyngeal and superior laryngeal nerves in mice.
    Arai T; Ohkuri T; Yasumatsu K; Kaga T; Ninomiya Y
    Neuroscience; 2010 Feb; 165(4):1476-89. PubMed ID: 19958811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat.
    Mills C; McMackin M; Jaffe R; Yu J; Zininberg E; Slee D; Gogas K; Bradbury M
    Neuroscience; 2008 Sep; 156(1):165-74. PubMed ID: 18706981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive desensitizing actions of TRPV1 receptor agonists capsaicin, resiniferatoxin and N-oleoyldopamine as measured by determination of the noxious heat and cold thresholds in the rat.
    Bölcskei K; Tékus V; Dézsi L; Szolcsányi J; Petho G
    Eur J Pain; 2010 May; 14(5):480-6. PubMed ID: 19800272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of transient receptor potential vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia.
    Kawamata T; Ji W; Yamamoto J; Niiyama Y; Furuse S; Namiki A
    Neuroscience; 2008 Jun; 154(3):1067-76. PubMed ID: 18495351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative roles of protein kinase A and protein kinase C in modulation of transient receptor potential vanilloid type 1 receptor responsiveness in rat sensory neurons in vitro and peripheral nociceptors in vivo.
    Varga A; Bölcskei K; Szöke E; Almási R; Czéh G; Szolcsányi J; Pethö G
    Neuroscience; 2006 Jun; 140(2):645-57. PubMed ID: 16564637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.